VJHemOnc is committed to improving our service to you

iwCLL 2019 | Frontline therapies for treatment naive CLL patients

VJHemOnc is committed to improving our service to you

Danielle Brander

Danielle Brander, MD, Duke University School of Medicine, Durham, NC, summarises therapies, practices and trials for frontline treatment of treatment naive CLL (chronic lymphocytic leukemia) patients at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter